Back to Agenda
Session 3 of Highlighted Presentations Followed by Q&A
Speaker(s)
Gilles Touraille, PHARMD, PHD
Scientific Administrator, European Medicines Agency, Netherlands
COVID-19 Vaccines – Impact on Eudravigilance, Coding Guidelines and Transparency Aspects
Rodrigo Postigo
Signal Management Lead, Pharmacovigilance Office, European Medicines Agency, Netherlands
COVID-19 Vaccines – Impact on Eudravigilance, Coding Guidelines and Transparency Aspects
Florence van Hunsel, PHARMD, PHD
Head Signal Detection, Netherlands Pharmacovigilance Centre Lareb, Netherlands
COVID-19 Vaccines ICRSRS – A National Competent Authority (NCA) Perspective
Have an account?
